RedGDPS
@redgdps.bsky.social
Fundación de la Red de Grupos de Estudio de la Diabetes en Atención Primaria. Comprometidos con la #diabetes.
" Ponle luz a la Diabetes", 4° #CongresoRedGDPS, 27-28 Noviembre en Valencia
www.redgdps.org
" Ponle luz a la Diabetes", 4° #CongresoRedGDPS, 27-28 Noviembre en Valencia
www.redgdps.org
Full text links
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
In Special Collection: ADA Medical Affairs Article Collection , Review Articles
David B. Sacks et al
diabetesjournals.org/care/article...
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
In Special Collection: ADA Medical Affairs Article Collection , Review Articles
David B. Sacks et al
diabetesjournals.org/care/article...
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
BACKGROUND. Numerous laboratory tests are used in the diagnosis and management of diabetes mellitus. The quality of the scientific evidence supporting the
diabetesjournals.org
December 18, 2025 at 5:27 PM
Full text links
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
In Special Collection: ADA Medical Affairs Article Collection , Review Articles
David B. Sacks et al
diabetesjournals.org/care/article...
Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
In Special Collection: ADA Medical Affairs Article Collection , Review Articles
David B. Sacks et al
diabetesjournals.org/care/article...
Acceso en @PubMedOnline
Risk differences and underlying FRCV events and mortality in patients with DM2 vs DM1: a longitudinal cohort study of Swedish nationwide register data
Vagia Patsoukaki et al. Lancet Diabetes Endocrinol.2025 Oct.
t.co/qON6rFVpEX
Risk differences and underlying FRCV events and mortality in patients with DM2 vs DM1: a longitudinal cohort study of Swedish nationwide register data
Vagia Patsoukaki et al. Lancet Diabetes Endocrinol.2025 Oct.
t.co/qON6rFVpEX
https://pubmed.ncbi.nlm.nih.gov/40876474/
t.co
December 11, 2025 at 4:41 PM
Acceso en @PubMedOnline
Risk differences and underlying FRCV events and mortality in patients with DM2 vs DM1: a longitudinal cohort study of Swedish nationwide register data
Vagia Patsoukaki et al. Lancet Diabetes Endocrinol.2025 Oct.
t.co/qON6rFVpEX
Risk differences and underlying FRCV events and mortality in patients with DM2 vs DM1: a longitudinal cohort study of Swedish nationwide register data
Vagia Patsoukaki et al. Lancet Diabetes Endocrinol.2025 Oct.
t.co/qON6rFVpEX
Full text links
Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study
diabetesjournals.org/care/article...
Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study
diabetesjournals.org/care/article...
Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study
OBJECTIVE. To assess the real-world frequency and characteristics associated with type 2 diabetes remission in a large and diverse cohort of U.S. adults.RE
diabetesjournals.org
December 4, 2025 at 4:39 PM
Full text links
Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study
diabetesjournals.org/care/article...
Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study
diabetesjournals.org/care/article...
Acceso en @PubMedOnline
Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study
Barune Thapa et al
PMID: 40734551 PMCID: PMC12451825 DOI: 10.2337/dc25-0530
Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study
Barune Thapa et al
PMID: 40734551 PMCID: PMC12451825 DOI: 10.2337/dc25-0530
December 4, 2025 at 4:39 PM
Acceso en @PubMedOnline
Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study
Barune Thapa et al
PMID: 40734551 PMCID: PMC12451825 DOI: 10.2337/dc25-0530
Clinical and Demographic Characteristics Associated With Diabetes Remission in Six Integrated Health Care Systems: A Retrospective Cohort Study
Barune Thapa et al
PMID: 40734551 PMCID: PMC12451825 DOI: 10.2337/dc25-0530
🚀 Si trabajas con evidencia científica o simplemente quieres comprender mejor lo que lees, #Mati te va a ahorrar horas y a mejorar la calidad de tus decisiones
🏃Esto es análisis científico, pero con #turbo
Tienes todo lo que hay que saber en el nuestro #BlogdeMateu
🏃Esto es análisis científico, pero con #turbo
Tienes todo lo que hay que saber en el nuestro #BlogdeMateu
November 23, 2025 at 5:29 PM
🚀 Si trabajas con evidencia científica o simplemente quieres comprender mejor lo que lees, #Mati te va a ahorrar horas y a mejorar la calidad de tus decisiones
🏃Esto es análisis científico, pero con #turbo
Tienes todo lo que hay que saber en el nuestro #BlogdeMateu
🏃Esto es análisis científico, pero con #turbo
Tienes todo lo que hay que saber en el nuestro #BlogdeMateu
📊🤓Además, añade un “Comentario de Mati” donde valora la calidad y relevancia real del estudio:
-Diseño, tamaño muestral, metodología, evidencia, impacto en la literatura…
🧠Vamos, lo que siempre deseas saber pero nadie tiene tiempo de revisar.
🤖#Mati trabaja por ti.
-Diseño, tamaño muestral, metodología, evidencia, impacto en la literatura…
🧠Vamos, lo que siempre deseas saber pero nadie tiene tiempo de revisar.
🤖#Mati trabaja por ti.
November 23, 2025 at 5:29 PM
📊🤓Además, añade un “Comentario de Mati” donde valora la calidad y relevancia real del estudio:
-Diseño, tamaño muestral, metodología, evidencia, impacto en la literatura…
🧠Vamos, lo que siempre deseas saber pero nadie tiene tiempo de revisar.
🤖#Mati trabaja por ti.
-Diseño, tamaño muestral, metodología, evidencia, impacto en la literatura…
🧠Vamos, lo que siempre deseas saber pero nadie tiene tiempo de revisar.
🤖#Mati trabaja por ti.
Así nos lo explica #CarlosHndezTeixido en este 🧵 👇🏼
🔰¿Leer artículos científicos sin morir en el intento?
🤖Os presento a #Mati, vuestro nuevo asistente de IA especializado en análisis científico. Abierto a todo el mundo
🧠Te explico brevemente cómo funciona para que puedas ahorrarte horas de trabajo
🔰¿Leer artículos científicos sin morir en el intento?
🤖Os presento a #Mati, vuestro nuevo asistente de IA especializado en análisis científico. Abierto a todo el mundo
🧠Te explico brevemente cómo funciona para que puedas ahorrarte horas de trabajo
November 23, 2025 at 5:29 PM
Así nos lo explica #CarlosHndezTeixido en este 🧵 👇🏼
🔰¿Leer artículos científicos sin morir en el intento?
🤖Os presento a #Mati, vuestro nuevo asistente de IA especializado en análisis científico. Abierto a todo el mundo
🧠Te explico brevemente cómo funciona para que puedas ahorrarte horas de trabajo
🔰¿Leer artículos científicos sin morir en el intento?
🤖Os presento a #Mati, vuestro nuevo asistente de IA especializado en análisis científico. Abierto a todo el mundo
🧠Te explico brevemente cómo funciona para que puedas ahorrarte horas de trabajo
Full text links
Comparison of an Energy-Reduced Dietamed and Physical Activity Versus an Ad Libitum Dietamed in the Prevention of Type 2 Diabetes: A Secondary Analysis of a Randomized Controlled Trial: Annals of Internal Medicine: Vol 178, No 10
www.acpjournals.org/doi/10.7326/...
Comparison of an Energy-Reduced Dietamed and Physical Activity Versus an Ad Libitum Dietamed in the Prevention of Type 2 Diabetes: A Secondary Analysis of a Randomized Controlled Trial: Annals of Internal Medicine: Vol 178, No 10
www.acpjournals.org/doi/10.7326/...
Comparison of an Energy-Reduced Mediterranean Diet and Physical Activity Versus an Ad Libitum Mediterranean Diet in the Prevention of Type 2 Diabetes: A Secondary Analysis of a Randomized Controlled T...
Background: Limited research has been done to evaluate the combined effect of energy reduction, Mediterranean diet (MedDiet), and physical activity on type 2 diabetes incidence. Objective: To evaluate...
www.acpjournals.org
November 20, 2025 at 9:32 PM
Full text links
Comparison of an Energy-Reduced Dietamed and Physical Activity Versus an Ad Libitum Dietamed in the Prevention of Type 2 Diabetes: A Secondary Analysis of a Randomized Controlled Trial: Annals of Internal Medicine: Vol 178, No 10
www.acpjournals.org/doi/10.7326/...
Comparison of an Energy-Reduced Dietamed and Physical Activity Versus an Ad Libitum Dietamed in the Prevention of Type 2 Diabetes: A Secondary Analysis of a Randomized Controlled Trial: Annals of Internal Medicine: Vol 178, No 10
www.acpjournals.org/doi/10.7326/...
Acceso en @PubMedOnline
Comparison of an Energy-Reduced Dietamed and Physical Activity Versus an Ad Libitum Dietamed in the Prevention of DM2: A Secondary Analysis of a Randomized Controlled Trial
Miguel Ruiz-Canela et al. Ann Intern Med. 2025 Oct.
t.co/mOjr6dSQGy
Comparison of an Energy-Reduced Dietamed and Physical Activity Versus an Ad Libitum Dietamed in the Prevention of DM2: A Secondary Analysis of a Randomized Controlled Trial
Miguel Ruiz-Canela et al. Ann Intern Med. 2025 Oct.
t.co/mOjr6dSQGy
https://pubmed.ncbi.nlm.nih.gov/40854218/
t.co
November 20, 2025 at 9:32 PM
Acceso en @PubMedOnline
Comparison of an Energy-Reduced Dietamed and Physical Activity Versus an Ad Libitum Dietamed in the Prevention of DM2: A Secondary Analysis of a Randomized Controlled Trial
Miguel Ruiz-Canela et al. Ann Intern Med. 2025 Oct.
t.co/mOjr6dSQGy
Comparison of an Energy-Reduced Dietamed and Physical Activity Versus an Ad Libitum Dietamed in the Prevention of DM2: A Secondary Analysis of a Randomized Controlled Trial
Miguel Ruiz-Canela et al. Ann Intern Med. 2025 Oct.
t.co/mOjr6dSQGy
Acceso en @PubMedOnline
Is Screening for Heart Failure and Peripheral Artery Disease Warranted in Asymptomatic Adults With Diabetes? A Perspective on the 2025 ADA "Standards of Care in Diabetes"
William H Herman et al. Diabetes Care. 2025.
pubmed.ncbi.nlm.nih.gov/40504992/
Is Screening for Heart Failure and Peripheral Artery Disease Warranted in Asymptomatic Adults With Diabetes? A Perspective on the 2025 ADA "Standards of Care in Diabetes"
William H Herman et al. Diabetes Care. 2025.
pubmed.ncbi.nlm.nih.gov/40504992/
Is Screening for Heart Failure and Peripheral Artery Disease Warranted in Asymptomatic Adults With Diabetes? A Perspective on the 2025 American Diabetes Association "Standards of Care in Diabetes" - PubMed
The American Diabetes Association (ADA) publishes the "Standards of Care in Diabetes" (SOC) annually to offer clinicians, patients, and payers evidence-based guidelines for diabetes management. The 2025 SOC recommends that clinicians consider screening asymptomatic adults with diabetes for heart fai …
pubmed.ncbi.nlm.nih.gov
November 16, 2025 at 4:10 PM
Acceso en @PubMedOnline
Is Screening for Heart Failure and Peripheral Artery Disease Warranted in Asymptomatic Adults With Diabetes? A Perspective on the 2025 ADA "Standards of Care in Diabetes"
William H Herman et al. Diabetes Care. 2025.
pubmed.ncbi.nlm.nih.gov/40504992/
Is Screening for Heart Failure and Peripheral Artery Disease Warranted in Asymptomatic Adults With Diabetes? A Perspective on the 2025 ADA "Standards of Care in Diabetes"
William H Herman et al. Diabetes Care. 2025.
pubmed.ncbi.nlm.nih.gov/40504992/